NDC codes

FDA NDC Directory
Product NDC (as listed)70069-860Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70069-0860Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70069-860-187006908601870069086018180 TABLET, DELAYED RELEASE in 1 BOTTLE (70069-860-18)Marketed from Aug 10, 2026
70069-860-30700690860307006908603030 TABLET, DELAYED RELEASE in 1 BOTTLE (70069-860-30)Marketed from Aug 10, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Acamprosate Calcium
Generic name (nonproprietary)
acamprosate calcium
Active ingredients
Acamprosate calcium — 333 mg/1
Dosage form
Tablet, Delayed release
Route
Oral
Labeler
Somerset Therapeutics, LLCNDC labeler code 70069
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 218984
Marketing start
Listing expires
Identifiers
Product ID 70069-860_1cfe4675-766f-4f1a-b1a8-96bbdacfcfa5SPL ID 1cfe4675-766f-4f1a-b1a8-96bbdacfcfa5SPL set ID 1cfe4675-766f-4f1a-b1a8-96bbdacfcfa5RxCUI 835726UNII 59375N1D0UUPC 0370069860182, 0370069860304

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470069086018 followed by a unit qualifier and the quantity

Package 70069-0860-18. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Acamprosate calcium is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium should be part of a comprehensive management program that includes psychosocial support. The efficacy of acamprosate calcium in promoting abstinence has not been demonstrated in subjects who have not undergone detoxification and not achieved alcohol abstinence prior to beginning acamprosate calcium treatment. The efficacy of acamprosate calcium in promoting abstinence from alcohol in polysubstance abusers has not been adequately assessed. Acamprosate calcium delayed-release tablets are indicated for t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70069-860

What is NDC 70069-860?
70069-860 is the product NDC for Acamprosate Calcium, Acamprosate calcium 333 mg/1 tablet, delayed release, listed with the FDA by Somerset Therapeutics, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Acamprosate Calcium.
What is the active ingredient?
Acamprosate calcium.
Who is the labeler?
Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Acamprosate Calcium?
10 other product NDCs are listed under this name. See all Acamprosate Calcium NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Acamprosate Calcium NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
acamprosate calciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralREMEDYREPACK INC.70518-461670518-4616-00
Acamprosate CalciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralNCS HealthCare of KY, LLC dba Vangard Labs0615-866000615-8660-39
Acamprosate CalciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralBionpharma Inc.,69452-35369452-0353-25
acamprosate calciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralZydus Pharmaceuticals (USA) Inc.68382-56968382-0569-0168382-0569-0568382-0569-06+3 more
acamprosate calciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralZydus Lifesciences Limited70771-105770771-1057-0070771-1057-0170771-1057-03+3 more
Acamprosate CalciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralAmerican Health Packaging60687-12160687-0121-25
Acamprosate Calciumacamprosate calcium enteric-coatedAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralMylan Pharmaceuticals Inc.0378-633300378-6333-80
Acamprosate Calciumacamprosate calcium enteric-coatedAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralNCS HealthCare of KY, LLC dba Vangard Labs0615-856000615-8560-39
Acamprosate CalciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralMajor Pharmaceuticals0904-721300904-7213-04
Acamprosate CalciumAcamprosate calcium 333 mg/1Tablet, Delayed releaseOralGlenmark Pharmaceuticals Inc., USA68462-43568462-0435-1168462-0435-18

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in